Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Sep 27, 2024; 16(9): 2829-2841
Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2829
Figure 2
Figure 2 Patient overall survival. A: Overall survival (OS); B-F: OS comparison by vascular invasion status (B), immunotherapy sequence (C), prior transarterial chemoembolization (D), combined targeted therapy (E) and treatment line of immunotherapy (F). OS: Overall survival; TACE: Transarterial chemoembolization.